- Amended Current report filing (8-K/A)
22 March 2010 - 11:00PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
8-K/A
Amendment
No. 1
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of
Report (Date of earliest event reported):
March 12, 2010
NEW
GENERATION BIOFUELS HOLDINGS, INC.
(Exact
Name of Registrant as Specified in Charter)
Florida
|
1-34022
|
26-0067474
|
(State
or other jurisdiction of incorporation)
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
5850
Waterloo Road, Suite 140
|
(Address
of principal executive offices)(Zip Code)
(410)
480-8084
(Registrant’s
telephone number, including area code)
N/A
(Former
Name or former address, if changed since last report.)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14-12)
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
o
|
Pre-commencement
communications pursuant to Rule 1 3-e-4(c) under the Exchange Act (17 CFR
240.1 3e-4(c))
|
EXPLANATORY
NOTE
We are filing this amendment to our
Current Report on Form 8-K, filed March 17, 2010, to disclose
additional information for our shareholders regarding
the proposed terms of our recently announced MOU. This amendment
does not update, amend or modify any other information set forth in the original
Form 8-K and does not reflect any events that may have occurred after the
original filing date.
ITEM
8.01 Other Events.
On March
12, 2010, New Generation Biofuels Holdings, Inc. (“NGBF”) and a potential
strategic partner from China, Regent Trend Investment Ltd
(soon to be
re-named Milestone Biofuels Limited, or Milestone) executed a non-binding
Memorandum of Understanding, or MOU, under which Milestone would invest $20
million in our equity securities and we would collaborate with Milestone to form
a joint venture to develop and operate biofuel production plants in the
continental United States with a capacity of 250 million gallons per year.
Milestone would fund all of the capital requirements for the joint venture and
NGBF would provide the technology and operate the plants. NGBF would earn
a minimum royalty on all sales from the joint venture and would share in a
percentage of profits above the minimum royalty.
The
indicative terms and conditions of the MOU are outlined in a financial term
sheet and a development and operation term sheet attached to the MOU. The
financial term sheet summarizes key terms of the potential investment by
Milestone of $20 million in our equity securities at closing. The first $10
million would be invested in the form of common stock at a price of $0.80 per
share and no warrants. For the second $10 million, Milestone has the option of
either common stock priced at $0.80 per share with no warrants or convertible
preferred stock with a 15% dividend and 2 million warrants with conversion or
exercise prices, respectively, of $1.50 per share. The entire $20 million would
be invested in NGBF at the time of closing, subject to compliance with any
relevant NASDAQ rules. Milestone also would have the option to nominate up to
three directors to our board.
The
development and operations term sheet outlines the parties' expectations with
respect to the structure of the business, the design, siting and schedule of
plant development, plant operations, allocation of research and development, and
other terms.
The MOU
remains subject to a due diligence period of up to 75 days and negotiation,
execution and delivery of definitive agreements acceptable to both parties and
approved by their respective boards of directors. The investment also may be
subject to shareholder approval under the NASDAQ listing rules. The parties
contemplate signing definitive agreements at the end of the due diligence
period, provided both parties successfully complete the process. Without
incurring any liability to the other party, either party may cease negotiations
at any time by providing written notice.
SIGNATURES
Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned, thereunto duly
authorized.
Date:
March 22, 2010
|
/s/ Cary
J. Claiborne
|
|
|
Name:
Cary J. Claiborne
|
|
|
Title:
President, Chief Executive Officer and Chief Financial
Officer
|
|
|
|
|
New Gen Biofuels (MM) (NASDAQ:NGBF)
Historical Stock Chart
From Sep 2024 to Oct 2024
New Gen Biofuels (MM) (NASDAQ:NGBF)
Historical Stock Chart
From Oct 2023 to Oct 2024